- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Can Fite Biopharma Ltd ADR is a biotechnology business based in the US. Can Fite Biopharma Ltd ADR shares (CANF) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $1.48 – a decrease of 6.33% over the previous week. Can Fite Biopharma Ltd ADR employs 8 staff and has a trailing 12-month revenue of around $667,000.
What's in this guide?
- CANF shares summary
- Compare share dealing platforms
- Is CANF stock a buy or sell?
- Stock performance over time
- Can I short CANF shares?
- Can Fite Biopharma Ltd ADR's financials
- How volatile are CANF shares?
- Does Can Fite Biopharma Ltd ADR pay a dividend?
- Have CANF shares ever split?
- Other common questions
Our top picks for where to buy Can Fite Biopharma Ltd ADR stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Can Fite Biopharma Ltd ADR stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CANF. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Can Fite Biopharma Ltd ADR stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Can Fite Biopharma Ltd ADR stock price (NYSE MKT: CANF)
Use our graph to track the performance of CANF stocks over time.Can Fite Biopharma Ltd ADR shares at a glance
Information last updated 2024-12-18.
| Latest market close | $1.48 |
|---|---|
| 52-week range | $1.29 - $4.69 |
| 50-day moving average | $2.13 |
| 200-day moving average | $2.38 |
| Wall St. target price | $14.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-2.60 |
Is it a good time to buy Can Fite Biopharma Ltd ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Can Fite Biopharma Ltd ADR price performance over time
Historical closes compared with the close of $1.48 from 2024-12-20
| 1 week (2024-12-13) | -6.33% |
|---|---|
| 1 month (2024-11-22) | -24.49% |
| 3 months (2024-09-20) | -25.25% |
| 6 months (2024-06-21) | -45.69% |
| 1 year (2023-12-22) | -29.52% |
|---|---|
| 2 years (2022-12-22) | -77.57% |
| 3 years (2021-12-22) | 14.1 |
| 5 years (2019-12-20) | 28.7 |
Can Fite Biopharma Ltd ADR financials
| Revenue TTM | $667,000 |
|---|---|
| Gross profit TTM | $810,000 |
| Return on assets TTM | -57.46% |
| Return on equity TTM | -157.62% |
| Profit margin | 0% |
| Book value | $0.00 |
| Market Capitalization | $8.7 million |
TTM: trailing 12 months
Can Fite Biopharma Ltd ADR share dividends
We're not expecting Can Fite Biopharma Ltd ADR to pay a dividend over the next 12 months.
Have Can Fite Biopharma Ltd ADR's shares ever split?
Can Fite Biopharma Ltd ADR's shares were split on a 1:10 basis on 8 January 2023 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Can Fite Biopharma Ltd ADR shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Can Fite Biopharma Ltd ADR shares which in turn could have impacted Can Fite Biopharma Ltd ADR's share price.
Can Fite Biopharma Ltd ADR share price volatility
Over the last 12 months, Can Fite Biopharma Ltd ADR's shares have ranged in value from as little as $1.29 up to $4.69. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Can Fite Biopharma Ltd ADR's is 0.567. This would suggest that Can Fite Biopharma Ltd ADR's shares are less volatile than average (for this exchange).
Can Fite Biopharma Ltd ADR overview
Can-Fite BioPharma Ltd. , a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cancer; and Phase IIa for the treatment of pancreatic cancer; as well as in Phase IIb trial for the treatment of metabolic associated steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops commercial predictive biomarker blood test kit for A3AR. It has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and collaboration agreement with Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. The company was formerly known as Can-Fite Technologies Ltd.
Frequently asked questions
nullWhat percentage of Can Fite Biopharma Ltd ADR is owned by institutions?
Currently 8.018% of Can Fite Biopharma Ltd ADR shares are held by institutions. How many people work for Can Fite Biopharma Ltd ADR?
Latest data suggests 8 work at Can Fite Biopharma Ltd ADR. When does the fiscal year end for Can Fite Biopharma Ltd ADR?
Can Fite Biopharma Ltd ADR's fiscal year ends in December. Where is Can Fite Biopharma Ltd ADR based?
Can Fite Biopharma Ltd ADR's address is: 26 Ben Gurion Street, Ramat Gan, Israel, 5257346 What is Can Fite Biopharma Ltd ADR's ISIN number?
Can Fite Biopharma Ltd ADR's international securities identification number is: US13471N2018 What is Can Fite Biopharma Ltd ADR's CUSIP number?
Can Fite Biopharma Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 13471N201
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question